ANNUAL REPORT 2021

LUNDBECK ANNUAL REPORT 2021 = CONTENTS Executive Management* DEBORAH DUNSIRE President and CEO - Born 1962 * Joined Lundbeck in 2018 Directorships * Syros Pharmaceuticals (M) • Ultragenyx Pharmaceutical Inc. (M) Holding of shares 7,739 LARS BANG Executive Vice President, Product Development & Supply • Born 1962 • Joined Lundbeck in 1988 Directorships .O.B. Holding Aps (M) Holding of shares 49,177 ANDERS GÖTZSCHE Executive Vice President, CFO Born 1967 Joined Lundbeck in 2007 Directorships ■ Obsidian Therapeutics (M) ⚫ DFDS (M) Rosborg Møbler A/S (C) Holding of shares 49,404 ELISE HAUGE *** Executive Vice President, People & Communication • Born 1967 • Joined Lundbeck in 2019 Directorships CBS Executive Fonden (M) Holding of shares 1,225 Per 31.12 2021 C=Chairman, DC Deputy Chairman, M = Member * For more information about Executive Management and their competencies, please visit https://www.lundbeck.com/global/about-us/our-leadership/executive-management Anders Götzsche steps down as CFO by the end of March 2022 *** Elise Hauge (Executive Vice President, People & Communication) and Keld Flintholm Jørgensen (Executive Vice President, Corporate Strategy & Business Development) participate in the Executive Management in their respective roles but are not members of the Executive Management as registered with the Danish Business Authority 45/111

View entire presentation